Pages with the most revisions
Appearance
Showing below up to 50 results in range #551 to #600.
- Sucralfate (2 revisions)
- Phentermine (2 revisions)
- Phenotype:NUDT15 normal metabolizer (2 revisions)
- Phenotype:CYP2C9 poor metabolizer (2 revisions)
- Meloxicam (2 revisions)
- Galcanezumab (2 revisions)
- Ivermectin (2 revisions)
- Acetaminophen (2 revisions)
- Hydrocortisone (2 revisions)
- Benazepril (2 revisions)
- Celecoxib (2 revisions)
- Olmesartan (2 revisions)
- Riboflavin (2 revisions)
- Linagliptin (2 revisions)
- TiHKAL (2 revisions)
- Famotidine (2 revisions)
- Cephalexin (2 revisions)
- Bimatoprost (2 revisions)
- Linaclotide (2 revisions)
- Yerba mate (2 revisions)
- Phenotype:CYP3A4 normal metabolizer (2 revisions)
- Dapagliflozin (2 revisions)
- Phenotype:CYP2D6 poor metabolizer (2 revisions)
- Alendronate (2 revisions)
- Isosorbide (2 revisions)
- Ketoconazole (2 revisions)
- Sitagliptin (2 revisions)
- Warfarin (2 revisions)
- Indomethacin (2 revisions)
- Form:Medicine (2 revisions)
- Metformin (2 revisions)
- Insulin Aspart (2 revisions)
- Pantoprazole (2 revisions)
- Apixaban (2 revisions)
- Azelastine (2 revisions)
- Moxifloxacin (2 revisions)
- Phenotype:UGT1A1 intermediate metabolizer (2 revisions)
- Oxybutynin (2 revisions)
- USLegal:DEA Schedule V (2 revisions)
- Oseltamivir (2 revisions)
- Eptinezumab (2 revisions)
- Sodium Chloride (2 revisions)
- Glimepiride (2 revisions)
- Dexamethasone (2 revisions)
- Naproxen (2 revisions)
- Penicillin G (2 revisions)
- Losartan (2 revisions)
- Aspirin (2 revisions)
- Sodium Fluoride (2 revisions)
- Dorzolamide (2 revisions)